Fibrinogen is a highly pleiotropic protein that is involved in the final step of the coagulation cascade, wound healing, inflammation, and angiogenesis. Heterozygous mutations in A alpha, B beta, or gamma fibrinogen-chain genes (FGA, FGB, FGG) have been described as being responsible for fibrinogen deficiencies (hypofibrinogenemia, hypo-dysfibrinogenemia, dysfibrinogenemia) and for more rare conditions, such as fibrinogen storage disease and hereditary renal amyloidosis. Instead, biallelic mutations have been associated with afibrinogenemia/severe hypofibrinogenemia, i.e., the severest forms of fibrinogen deficiency, affecting approximately 1-2 cases per million people. However, the "true" prevalence for these conditions on a global scale is currently not available. Here, we defined the mutational burden of the FGA, FGB, and FGG genes, and estimated the prevalence of inherited fibrinogen disorders through a systematic analysis of exome/genome data from similar to 140,000 individuals belonging to the genome Aggregation Database. Our analysis showed that the world-wide prevalence for recessively-inherited fibrinogen deficiencies could be 10-fold higher than that reported so far (prevalence rates vary from 1 in 10(6) in East Asians to 24.5 in 10(6) in non-Finnish Europeans). The global prevalence for autosomal-dominant fibrinogen disorders was estimated to be similar to 11 in 1000 individuals, with heterozygous carriers present at a frequency varying from 3 every 1000 individuals in Finns, to 1-2 every 100 individuals among non-Finnish Europeans and Africans/African Americans. Our analysis also allowed for the identification of recurrent (i.e., FGG-p. Ala108Gly, FGG-Thr47Ile) or ethnic-specific mutations (e.g., FGB-p. Gly103Arg in Admixed Americans, FGG-p.Ser245Phe in Africans/African Americans).
|Titolo:||Fibrinogen as a Pleiotropic Protein Causing Human Diseases: The Mutational Burden of A alpha, B beta, and gamma Chains|
|Data di pubblicazione:||2017|
|Appare nelle tipologie:||1.1 Articolo in rivista|